piperonyl butoxide has been researched along with vanoxerine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pai, KS; Ravindranath, V; Sriram, K | 1 |
1 other study(ies) available for piperonyl butoxide and vanoxerine
| Article | Year |
|---|---|
Protection and potentiation of 1-methyl-4-phenylpyridinium-induced toxicity by cytochrome P450 inhibitors and inducer may be due to the altered uptake of the toxin.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Biological Transport; Brain; In Vitro Techniques; Male; Mice; Monoamine Oxidase Inhibitors; Phenobarbital; Piperazines; Piperonyl Butoxide; Proadifen | 1995 |